OrthoPediatrics director sells 22,500 shares
ORTHOPEDIATRICS CORP (KIDS) reported that director and ten percent owner David R. Pelizzon, through affiliated entity Squadron Capital LLC, indirectly sold 22,500 shares of common stock on September 2, 2026 at a weighted average price of $23.35 per share.
Rhea-AI Filing Summary
ORTHOPEDIATRICS CORP (KIDS) reported that director and ten percent owner David R. Pelizzon, through affiliated entity Squadron Capital LLC, indirectly sold 22,500 shares of common stock on September 2, 2026 at a weighted average price of $23.35 per share. The sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. After this transaction, entities associated with Pelizzon held 6,504,133 indirect shares and he held 44,384 shares directly, including 17,959 restricted stock awards, while he expressly disclaims beneficial ownership of Squadron’s shares except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 22,500 shares
Net Sell
2 txns
Insider
Pelizzon David R
Role
Director, 10% Owner
Sold
22,500 shs ($525K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2, F3 | 22,500 | $23.35 | $525K |
| holding | Common Stock F4 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 6,504,133 shares (Indirect, See footnote);
Common Stock — 44,384 shares (Direct)
Footnotes (4)
- F1. This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.01 to $23.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3. These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
- F4. Includes restricted stock awards totaling 17,959 shares.
Key Figures
Shares sold: 22,500 shares
Weighted average sale price: $23.35 per share
Sale price range: $23.01–$23.74 per share
+3 more
6 metrics
Shares sold
22,500 shares
Common stock sold on September 2, 2026 by Squadron Capital LLC
Weighted average sale price
$23.35 per share
Average price for the 22,500 KIDS shares sold on September 2, 2026
Sale price range
$23.01–$23.74 per share
Range of prices for the multiple sale transactions on September 2, 2026
Indirect holdings after transaction
6,504,133 shares
Indirect KIDS common stock reported after the sale, held through affiliated entity
Direct holdings after transaction
44,384 shares
Direct KIDS common stock reported held by Pelizzon after the sale
Restricted stock awards included in direct holdings
17,959 shares
Restricted stock awards included within Pelizzon’s 44,384 directly held shares
Key Terms
weighted average price, beneficial owner, pecuniary interest, restricted stock awards, +1 more
5 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial owner regulatory
"the reporting person may be deemed to be the beneficial owner of these shares."
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
pecuniary interest financial
"disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein."
restricted stock awards financial
"Includes restricted stock awards totaling 17,959 shares."
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
Section 16 regulatory
"shall not be deemed to be an admission of beneficial ownership for purposes of Section 16"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
FAQ
What insider transaction did ORTHOPEDIATRICS CORP (KIDS) report for David R. Pelizzon?
On September 2, 2026, an entity associated with director and ten percent owner David R. Pelizzon sold 22,500 KIDS shares of common stock at a weighted average price of $23.35 per share in open-market or private transactions.
Was the KIDS insider sale made under a Rule 10b5-1 trading plan?
The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed, and no footnote states that the September 2, 2026 sale was made pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
